Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Salem

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancerLawrence Kleinberg, Jonathan P S Knisely, Richard Heitmiller, et al.
Cancer Journal (Sudbury, Mass.)|September 1, 2007
Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancerBarbara Burtness, Laurie Thomas, Rebecca Sipples, et al.
Annals of Surgical Oncology|May 19, 2021
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)Irvin M Modlin, Mark Kidd, Kjell Oberg, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
International Journal of Radiation Oncology, Biology, Physics|May 10, 2003
Mature survival results with preoperative cisplatin, protracted infusion 5-fluorouracil, and 44-Gy radiotherapy for esophageal cancerLawrence Kleinberg, Jonathan P S Knisely, Richard Heitmiller, et al.
Cancer Journal (Sudbury, Mass.)|September 1, 2007
Phase II trial of weekly docetaxel/irinotecan combination in advanced pancreatic cancerBarbara Burtness, Laurie Thomas, Rebecca Sipples, et al.
Annals of Surgical Oncology|May 19, 2021
Early Identification of Residual Disease After Neuroendocrine Tumor Resection Using a Liquid Biopsy Multigenomic mRNA Signature (NETest)Irvin M Modlin, Mark Kidd, Kjell Oberg, et al.
Pageof 2